ReviewNaunyn-Schmiedeberg's archives of pharmacology2022

Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition.

Huimin Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.